Skip to main content
. 2021 May 19;14(5):486. doi: 10.3390/ph14050486

Scheme 1.

Scheme 1

Niclosamide greatly inhibits SARS-CoV-2 virus through three mechanisms, (i) inhibiting endocytosis through hACE2 (human angiotensin converting enzyme-2 receptor); (ii) blocking autophagy; and (iii) inhibiting viral replications.